Spin-off for chemical safety

Leiden University – towards a spin-off for chemical safety assessment

When chemicals injure cells, that injury initiates response pathways that signal stress in the cells. The strong activation of these pathways signals the onset of toxicity.

Using genetically-engineered biomarkers with fluorescent proteins, Leiden University has developed over 50 different cell lines that “report” such stress response pathways. Live cell confocal microscopy accurately quantifies activation of these stress pathways (upon chemical exposure) over time, while automated image acquisition and analysis allows efficient and cost- effective high throughput screening.

The goal is to provide detailed mechanistic information allowing temporal dynamics of stress proteins on a single cell or population level, which will result in a toxicity liability score to rank the chemicals based on maladaptive pathway activation and, ultimately, dose response modelling of treatment effects. This information will contribute to safe design for green chemistry and drug development.  

The 50-plus reporter cell lines cover a wide range of stress pathways, e.g. oxidative stress, ER stress/unfolded protein stress, inflammation, DNA damage, heat shock stress, heavy metal stress, autophagy and hypoxia.

This platform is currently being incorporated in a spin-off company that will offer contract research. The imaging-based cell stress reporter platform is unique in that it allows:

  • Improved prediction of target organ toxicity testing
  • Temporal and quantitative analysis of cellular stress response activation
  • Single cell as well as population dynamics analysis
  • Applications for drug discovery to modulate cell stress response signaling

 

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (3 weeks ago)
RT @iseult5: @nanocommons month18 meeting well underway! Updates from Cristiana on project status and @EdelweissConn Thomas Exner on our #n…
Edelweiss Connect (3 weeks ago)
RT @openrisknet: We are pleased to announce the final @OpenRiskNet workshop that will be organised in #Amsterdam, The Netherlands on 23-24…
Edelweiss Connect (3 weeks ago)
RT @MauriceAtEcvam: We're hiring! If you are specialist in organ-on-chip technologies and systems then please apply to come join our team @…
Edelweiss Connect (3 weeks ago)
RT @nanotechia: Come say hi to @EdelweissConn at #Nanopavilion2019 Stand B316 at #ChemspecEurope ! #nano #nanomaterials #nanotechnology ht…
Edelweiss Connect (4 weeks ago)
Learn more about our recently launched application at #Chemspec Europe 2019. SaferSkin uses an ITS approach to prov… https://t.co/AVDsDMgrVE

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com